FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A

BACKGROUND: Docetaxel resistance affects prognosis in advanced prostate cancer (PCa). The precise mechanisms remain unclear. Transcription factor Forkhead box M1 (FOXM1), which participates in cell proliferation and cell cycle progression, has been reported to affect the sensitivity of chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hongbo, Xu, Zheng, Guo, Maomao, Wang, Weiwan, Zhang, Weican, Liang, Sudong, Xu, Zhibin, Ye, Jun, Zhu, Gangyi, Zhang, Chenyang, Lin, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653758/
https://www.ncbi.nlm.nih.gov/pubmed/33292277
http://dx.doi.org/10.1186/s12935-020-01631-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653758/
https://www.ncbi.nlm.nih.gov/pubmed/33292277
http://dx.doi.org/10.1186/s12935-020-01631-y

Ejemplares similares